# Lynx MD

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lynx-md

- Industry: Healthcare IT
- Headquarters: Palo Alto, US
- Website: www.lynx.md
- Total disclosed funding: $12M
- Latest round: Seed (Dec 13, 2021)
- Investors on record: 6

## About

Lynx MD, Ltd. is a healthcare technology firm focused on transforming patient data management through innovative analytics and secure data-sharing solutions, enhancing operational efficiency and patient care outcomes.Lynx MD, Ltd. specializes in creating a data-sharing ecosystem for healthcare, established in 2018 and headquartered in Palo Alto, US. The company was co-founded by Ofir Farchy and is led by CEO Omer Dror. In December 2021, it raised USD 12.00 mn in SEED funding, co-led by investors including Amdocs, Inc., MizMaa Ventures, and several others. Lynx MD has conducted one deal to date with the most recent deal occurring in December 2021.Lynx MD offers a comprehensive data-sharing ecosystem designed to revolutionize healthcare through the seamless integration of structured and unstructured patient data. Their core products include advanced analytics tools and a secure research platform that enables healthcare practices, medtech companies, and life science organizations to access and analyze vast amounts of real-world patient data, which includes over 400 million patient records. By facilitating access to diverse data types, such as medical images, physician notes, and lab results, Lynx MD aims to enhance research and development efforts, expedite clinical trials, and drive improvements in patient care outcomes. This solution serves a global client base, particularly within North America, Europe, and parts of Asia, empowering healthcare providers and researchers to uncover gaps in care and harness data for innovative healthcare solutions.Lynx MD generates revenue primarily through subscription-based models and partnerships with healthcare organizations, medtech firms, and life science companies. Clients typically engage with Lynx MD to leverage its secure platform for accessing real-world data, which facilitates comparative effectiveness research, clinical development, and artificial intelligence applications in healthcare. The firm structures its revenue through agreements that provide access to its data-sharing platform and analytics solutions, supporting clients in their research and operational needs. These partnerships are instrumental in allowing clients to monetize their data while gaining insights that can lead to improved patient outcomes. Lynx MD's offerings are particularly valuable to organizations focused on enhancing healthcare delivery and advancing medical research.Lynx MD plans to expand its commercial efforts in the US and its research and development team in Israel using the recent funding of USD 12.00 mn raised in December 2021. The company is focusing on enhancing customer success, sales, and marketing teams to support its growth strategy. Additionally, Lynx MD aims to introduce new products designed to further integrate health data solutions, although specific release dates for these products have not been announced. The expansion into new markets will be guided by the insights gained from the funding, supporting its mission to enhance healthcare delivery globally.

## Funding rounds

- Seed, Dec 13, 2021, $12M — Amdocs, Inc., Triventures, UpWest, MizMaa Ventures, NYL Ventures, iAngels

## Investors

- Amdocs, Inc. — Seed
- Triventures (https://capitalatlas.ai/funds/triventures) — Seed
- UpWest (https://capitalatlas.ai/funds/upwest) — Seed
- MizMaa Ventures (https://capitalatlas.ai/funds/mizmaa-ventures) — Seed
- NYL Ventures (https://capitalatlas.ai/funds/nyl-ventures) — Seed
- iAngels (https://capitalatlas.ai/funds/iangels) — Seed